The Gaithersburg research and development arm of AstraZeneca said it would begin filing a new request for Food and Drug Administration approval for its biologics annually starting this year.
{iframe}http://www.bizjournals.com/washington/news/2016/09/16/medimmune-is-meeting-a-bold-goal-it-set-all-the.html?ana=e_du_prem&s=article_du&ed=2016-09-16&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1474299820&j=75813512{/iframe}